Collaboration has multiple designs for prefilled and other syringes in the works
Bundling medical device user research, design, and mechanical innovation with manufacturing expertise in a single-source service offering is the objective of a marketing agreement between injectables component maker West and Chicago-based medical device developer Insight Product Development LLC. “It’s a relatively straightforward value proposition,” says Chris Evans, manager for innovation concepts at West, of the design-through-manufacturing offering. “Many clients are familiar with using consultants for design and mechanical innovation, but not necessarily with having one team handle the process.”
Clinicians, patients, and doctors sometimes have difficulty articulating what they like or dislike in a medical device, or describing the features they want, says Evans. “You have to extract it from them.” That’s what Insight brings to the deal—years of medical device user research. It combines that knowledge with product development methods that integrate compliance and FDA requirements, he says. “Insight provides West customers with access to more than 20 years of experience in product development, conceptual design, and research methods capabilities.”
Lionville, PA-based West brings components expertise to the deal, thanks to its experience in manufacturing such drug-administration safety devices as stoppers and seals for vials and plungers, as well as prefillable syringe components. West is also tapping the injection molding expertise of The Tech Group, a Scottsdale, AZ, contract manufacturer it acquired in 2005.
Evans says West made a corporate decision to be more than a maker of component rubber compound products. “We wanted to become a developer of design platforms, and of the intellectual property to be used.”
West and Insight have been working together for two years and have “a lot of syringe and injectable product designs that are still top secret,” Evans says. One example that he can discuss is Confidose, a disposable auto-injector system for self-injection therapy that was announced last fall. It’s in the final stages of development and not yet on the market, but West is showing it to clients.
Confidose incorporates an affixed needle prefilled syringe format that can be used with either a glass or crystalline plastic syringe. When the user presses a button, a needle extends to deliver a dose of medication and then retracts. After use, the needle is shielded within the system to prevent needle-stick injury and to make the system safe for disposal. Confidose is assembled by the pharmaceutical manufacturer with individual doses of medication in prefilled syringes.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.